Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia

Published:2000-04 Issue:2 Volume:149 Page:421-425
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Sijbrands Eric J.G,Westendorp Rudi G.J,Paola Lombardi M,Havekes Louis M,Frants Rune R,Kastelein John J.P,Smelt Augustinus H.M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Familial hypercholesterolemia;Goldstein,1995

2. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia;Hobbs;Hum. Mutat.,1992

3. Anonymous. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991;303:893–6.

4. Characteristic features of long-living patients with familial hypercholesterolemia in Japan;Murano;J. Am. Geriatr. Soc.,1993

5. Angina pectoris in hereditary xanthomatosis;Müller;Arch. Int. Med.,1939

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia;Journal of Clinical Medicine;2024-04-14

2. Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?;Current Atherosclerosis Reports;2022-04-07

3. Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel;Journal of Clinical Medicine;2021-10-25

4. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels;Trends in Cardiovascular Medicine;2021-05

5. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia;Atherosclerosis Supplements;2019-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3